The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Vardenafil Krka 5mg film-coated tablets

5 milligram(s) Film-coated tablet

Krka d.d., Novo mestoPA1347/073/001

Main Information

Trade NameVardenafil Krka 5mg film-coated tablets
Active SubstancesVardenafil hydrochloride trihydrate
Strength5 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderKrka d.d., Novo mesto
Licence NumberPA1347/073/001

Group Information

ATC CodeG04BE Drugs used in erectile dysfunction
G04BE09 vardenafil

Status

Authorised/WithdrawnAuthorised
Licence Issued28/04/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back